ProCatid Medical

Embolic Protection Solutions

Health Tech & Life Sciences
Active
Mature Caesarea, Israel Founded 2006
Last updated 2026-06-18
Total raised
Stage
Mature
Founded
2006
Headcount
2
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences

About

ProCatid Medical is the developer of WIRION, a distal embolic protection system composed of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires, according to physician preference. The unit can be placed anywhere on the wire using minimally invasive interventional procedures. The WIRION system allows the physician to use any 0.014-inch guide wire of choice throughout the entire procedure, cross challenging anatomies, and lock the filter on the same guide wire anywhere along the wire. The one-size system covers vessels ranging between 3.5 mm and 6.0 mm in diameter. Its uniform 120-micron pore filter provides continuous blood flow while maintaining embolic capture efficiency. It is currently designed for use in stenting procedures, including carotid, renal, lower limb, coronary, and SVG angioplasty. The system is CE marked and FDA cleared. ProCatid Medical is a subsidiary of Allium Medical, which develops minimally invasive solutions for treating chronic progressive diseases. In August 2019, the ProCatid Medical entered into an asset purchase agreement with Cardiovascular Systems Inc for the acquisition of certain assets and rights in relation to the WIRION system.

Q&A

What is ProCatid Medical's primary product?
ProCatid Medical develops WIRION, a distal embolic protection system featuring an independent filter unit that can be deployed on any commercially marketed guide wires.
What medical procedures is the WIRION system designed for?
The WIRION system is designed for use in stenting procedures, including carotid, renal, lower limb, coronary, and SVG angioplasty.
What regulatory clearances does the WIRION system have?
The WIRION system is CE marked and FDA cleared.
When was ProCatid Medical founded?
ProCatid Medical was founded in December 2006.
What is ProCatid Medical's employee count?
ProCatid Medical has 1-10 employees.
What is the relationship between ProCatid Medical and Allium Medical?
ProCatid Medical is a subsidiary of Allium Medical, which specializes in developing minimally invasive solutions for chronic progressive diseases.
Has ProCatid Medical been involved in any acquisitions?
In August 2019, ProCatid Medical entered into an asset purchase agreement with Cardiovascular Systems Inc for the acquisition of certain assets and rights related to the WIRION system.
What is ProCatid Medical's primary sector?
ProCatid Medical's primary sector is Health Tech & Life Sciences, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.

Team · 1

Founder · Founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

cardiologystentmedical-deviceshospitalsdoctorsmedical-technologiescardiovascularsurgeryminimally-invasive
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Former namesGardia Medical
Founded2006-12
Employees (exact)2